5th Circ. Shoots Down Challenge To Vioxx Settlement

Law360, New York (July 19, 2010, 6:00 PM EDT) -- A federal appeals court has rejected a challenge to Merck & Co.'s $4.85 billion settlement of the multidistrict litigation over its painkiller Vioxx by a group of nonsettling plaintiffs and affirmed the dismissal of their cases.

In an opinion handed down Friday, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit ruled that the appellants, known as the Dier plaintiffs, lacked standing to challenge the so-called master settlement agreement.

“Because the MSA was structured as an 'opt-in' private settlement rather than an...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.